Chugai Pharmaceutical
Clinical trials sponsored by Chugai Pharmaceutical, explained in plain language.
-
New hope for Hard-to-Treat cancers: first human trial of AUBE00 begins
Disease control Recruiting nowThis early-stage study tests a new drug called AUBE00 in about 90 to 130 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants must have a …
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New drug targets immune attack in six diseases
Disease control Recruiting nowThis early-stage trial tests a new drug called RAY121 in 144 adults with one of six immune diseases: antiphospholipid syndrome, bullous pemphigoid, Behçet's syndrome, dermatomyositis, immune-mediated necrotizing myopathy, or immune thrombocytopenia. The drug blocks a part of the …
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
New hope for celiac sufferers: drug targets gut damage despite Gluten-Free diet
Disease control Recruiting nowThis study tests a drug called DONQ52 in people with active celiac disease who still have gut damage and symptoms even after trying a gluten-free diet. The goal is to see if the drug can heal the small intestine and reduce symptoms like belly pain and bloating. About 92 adults wi…
Phase: PHASE2 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 26, 2026 03:51 UTC
-
New hope for tough lung cancer: ALPS12 drug trial begins
Disease control Recruiting nowThis early-phase study tests a new drug, ALPS12, in about 122 adults with extensive-stage small cell lung cancer that has come back after at least one prior treatment. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participant…
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 22, 2026 13:54 UTC